EcoDrugPlus

60s Ribosomal Protein L18

Ensembl ID : ENSCING00000013017
Gene Symbol: LOC100179092
4 Cross references
389 Possible Orthologues:

60s Ribosomal Protein L18a

Ensembl ID : ENSCING00000005643
Gene Symbol: LOC100182402
4 Cross references
375 Possible Orthologues:

60s Ribosomal Protein L21-Like

Ensembl ID : ENSCING00000011581
Gene Symbol: LOC108951018
4 Cross references
789 Possible Orthologues:

60s Ribosomal Protein L22-Like

Ensembl ID : ENSCING00000017452
Gene Symbol: LOC108949278
4 Cross references
461 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSCING00000003981
Gene Symbol: LOC100175749
4 Cross references
478 Possible Orthologues:

60s Ribosomal Protein L27

Ensembl ID : ENSCING00000016078
Gene Symbol: LOC100186399
4 Cross references
375 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : ENSCING00000006731
Gene Symbol: LOC100177118
4 Cross references
530 Possible Orthologues:

60s Ribosomal Protein L30

Ensembl ID : ENSCING00000016236
Gene Symbol: LOC100183305
4 Cross references
522 Possible Orthologues:

60s Ribosomal Protein L31

Ensembl ID : ENSCING00000011538
Gene Symbol: LOC100180716
4 Cross references
654 Possible Orthologues:

60s Ribosomal Protein L35

Ensembl ID : ENSCING00000008155
Gene Symbol: LOC100179536
4 Cross references
322 Possible Orthologues:

60s Ribosomal Protein L5

Ensembl ID : ENSCING00000008370
Gene Symbol: LOC100186763
4 Cross references
541 Possible Orthologues:

60s Ribosomal Protein L6

Ensembl ID : ENSCING00000000730
Gene Symbol: LOC100186361
4 Cross references
488 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).